Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: A microsimulation model

    Access Status
    Open access via publisher
    Authors
    Meester, R.
    Doubeni, C.
    Lansdorp-Vogelaar, Iris
    Jensen, C.
    Van Der Meulen, M.
    Levin, T.
    Quinn, V.
    Schottinger, J.
    Zauber, A.
    Corley, D.
    Van Ballegooijen, M.
    Date
    2015
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Meester, R. and Doubeni, C. and Lansdorp_Vogelaar, I. and Jensen, C. and Van Der Meulen, M. and Levin, T. and Quinn, V. et al. 2015. Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: A microsimulation model. JAMA - Journal of the American Medical Association. 313 (23): pp. 2349-2358.
    Source Title
    JAMA - Journal of the American Medical Association
    DOI
    10.1001/jama.2015.6251
    ISSN
    0098-7484
    URI
    http://hdl.handle.net/20.500.11937/49967
    Collection
    • Curtin Research Publications
    Abstract

    Importance: Colonoscopy is the most commonly used colorectal cancer screening test in the United States. Its quality, as measured by adenoma detection rates (ADRs), varies widely among physicians, with unknown consequences for the cost and benefits of screening programs. Objective: To estimate the lifetime benefits, complications, and costs of an initial colonoscopy screening program at different levels of adenoma detection. Design, Setting, and Participants: Microsimulation modeling with data from a community-based health care system on ADR variation and cancer risk among 57 588 patients examined by 136 physicians from 1998 through 2010. Exposures: Using modeling, no screening was compared with screening initiation with colonoscopy according to ADR quintiles (averages 15.3%, quintile 1; 21.3%, quintile 2; 25.6%, quintile 3; 30.9%, quintile 4; and 38.7%, quintile 5) at ages 50, 60, and 70 years with appropriate surveillance of patients with adenoma. Main Outcomes and Measures: Estimated lifetime colorectal cancer incidence and mortality, number of colonoscopies, complications, and costs per 1000 patients, all discounted at 3%per year and including 95%confidence intervals from multiway probabilistic sensitivity analysis. Results: In simulation modeling, among unscreened patients the lifetime risk of colorectal cancer incidence was 34.2 per 1000 (95%CI, 25.9-43.6) and risk of mortality was 13.4 per 1000 (95%CI, 10.0-17.6). Among screened patients, simulated lifetime incidence decreased with lower to higher ADRs (26.6; 95%CI, 20.0-34.3 for quintile 1 vs 12.5; 95%CI, 9.3-16.5 for quintile 5) as did mortality (5.7; 95%CI, 4.2-7.7 for quintile 1 vs 2.3; 95%CI, 1.7-3.1 for quintile 5). Compared with quintile 1, simulated lifetime incidence was on average 11.4%(95%CI, 10.3%-11.9%) lower for every 5 percentage-point increase of ADRs and for mortality, 12.8% (95%CI, 11.1%-13.7%) lower. Complications increased from 6.0 (95%CI, 4.0-8.5) of 2777 colonoscopies (95%CI, 2626-2943) in quintile 1 to 8.9 (95%CI, 6.1-12.0) complications of 3376 (95%CI, 3081-3681) colonoscopies in quintile 5. Estimated net screening costs were lower from quintile 1 (US $2.1 million, 95%CI, $1.8-$2.4 million) to quintile 5 (US $1.8 million, 95%CI, $1.3-$2.3 million) due to averted cancer treatment costs. Results were stable across sensitivity analyses. CONCLUSIONS AND RELEVANCE: In this microsimulation modeling study, higher adenoma detection rates in screening colonoscopy were associated with lower lifetime risks of colorectal cancer and colorectal cancer mortality without being associated with higher overall costs. Future research is needed to assess whether increasing adenoma detection would be associated with improved patient outcomes.

    Related items

    Showing items related by title, author, creator and subject.

    • Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: Study design
      Rigter, L.; Spaander, M.; Moons, L.; Bisseling, T.; Aleman, B.; de Boer, J.; Lugtenburg, P.; Janus, C.; Petersen, E.; Roesink, J.; Raemaekers, J.; van der Maazen, R.; Cats, A.; Bleiker, E.; Snaebjornsson, P.; Carvalho, B.; Lansdorp_Vogelaar, Iris; Józwiak, K.; te Riele, H.; Meijer, G.; van Leeuwen, F.; van Leerdam, M. (2017)
      Background: Second primary malignancies are a major cause of excess morbidity and mortality in cancer survivors. Hodgkin lymphoma survivors who were treated with infradiaphragmatic radiotherapy and/or high-dose procarbazine ...
    • Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test
      Meester, R.; Zauber, A.; Doubeni, C.; Jensen, C.; Quinn, V.; Helfand, M.; Dominitz, J.; Levin, T.; Corley, D.; Lansdorp_Vogelaar, Iris (2016)
      Background & Aims: Delays in diagnostic testing after a positive result from a screening test can undermine the benefits of colorectal cancer (CRC) screening, but there are few empirical data on the effects of such delays. ...
    • Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths
      Zauber, A.; Winawer, S.; O'Brien, M.; Lansdorp_Vogelaar, Iris; Van Ballegooijen, M.; Hankey, B.; Shi, W.; Bond, J.; Schapiro, M.; Panish, J.; Stewart, E.; Waye, J. (2012)
      BACKGROUND: In the National Polyp Study (NPS), colorectal cancer was prevented by colonoscopic removal of adenomatous polyps. We evaluated the long-term effect of colonoscopic polypectomy in a study on mortality from ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.